1. Home
  2. CNTB vs KUKE Comparison

CNTB vs KUKE Comparison

Compare CNTB & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • KUKE
  • Stock Information
  • Founded
  • CNTB 2012
  • KUKE 2002
  • Country
  • CNTB United States
  • KUKE China
  • Employees
  • CNTB N/A
  • KUKE N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • KUKE Other Consumer Services
  • Sector
  • CNTB Health Care
  • KUKE Real Estate
  • Exchange
  • CNTB Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • CNTB 44.2M
  • KUKE 86.8M
  • IPO Year
  • CNTB 2021
  • KUKE 2021
  • Fundamental
  • Price
  • CNTB $0.98
  • KUKE $2.93
  • Analyst Decision
  • CNTB Strong Buy
  • KUKE
  • Analyst Count
  • CNTB 2
  • KUKE 0
  • Target Price
  • CNTB $7.50
  • KUKE N/A
  • AVG Volume (30 Days)
  • CNTB 92.2K
  • KUKE 8.5K
  • Earning Date
  • CNTB 05-15-2025
  • KUKE 07-31-2025
  • Dividend Yield
  • CNTB N/A
  • KUKE N/A
  • EPS Growth
  • CNTB N/A
  • KUKE N/A
  • EPS
  • CNTB N/A
  • KUKE N/A
  • Revenue
  • CNTB $26,033,000.00
  • KUKE $9,442,397.00
  • Revenue This Year
  • CNTB N/A
  • KUKE N/A
  • Revenue Next Year
  • CNTB N/A
  • KUKE N/A
  • P/E Ratio
  • CNTB N/A
  • KUKE N/A
  • Revenue Growth
  • CNTB N/A
  • KUKE N/A
  • 52 Week Low
  • CNTB $0.51
  • KUKE $1.45
  • 52 Week High
  • CNTB $1.73
  • KUKE $17.50
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 59.56
  • KUKE 33.69
  • Support Level
  • CNTB $0.91
  • KUKE $2.95
  • Resistance Level
  • CNTB $1.12
  • KUKE $3.03
  • Average True Range (ATR)
  • CNTB 0.08
  • KUKE 0.11
  • MACD
  • CNTB 0.01
  • KUKE 0.01
  • Stochastic Oscillator
  • CNTB 59.26
  • KUKE 1.82

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: